Wednesday, March 29, 2023


Biotechnology News Magazine


GynTect Test for Cervical Cancer Ideal for Clarification in Case of Positive HPV Result

GynTect is well suited for sampling by the patient herself (self-sampling). All these points are confirmed by a recently published study from China.

Hansa Biopharma Announces Positive Reimbursement Decision for Idefirix® (imlifidase) in the Czech Republic

Availability of Idefirix for eligible highly sensitized patients to begin January 1, 2023.

Brand Institute Partners on Nonproprietary Name for Novel Protein Degrader Under Development by Arvinas, Inc.

Bavdegalutamide, also referred to as ARV-110, was published as a recommended INN in April of 2022. The product was granted fast-track designation by the FDA in May of 2019 for the treatment of metastatic castration-resistant prostate cancer.

AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development

Dr. Andrea Pfeifer, CEO of AC Immune SA, commented: “The selection of ACI-35.030 for further development is a significant step for this collaboration. Early clinical testing showed that ACI-35.030 was generally well tolerated and induced specific activity against the pathological species of Tau, including the neurotoxic pTau and enriched paired helical filaments (ePHF) species, both of which are closely implicated in Alzheimer’s disease (AD).

KSL | Pulse Scientific Named National Distributor in Canada for First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

KSL | Pulse Scientific, specializing in diagnostic, medical and laboratory products, announced today national distribution of the first and only over-the-counter combination test for...

Gyros Protein Technologies Adds Gyrolab® Biomarker Kits to Expand Range of Ready-to-Use Kits and Reagents

The new Gyrolab® Human Cytokine Kit Reagents are optimized for use on all Gyrolab systems, offer improved assay performance, and meet key customer needs to face the biomarker assay development challenges encountered during drug development programs and regulatory studies.